| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7525 [J. S., W. K. F., B. E. W.]; Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224 [W. W.]; and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599-7295 [D. N. R., B. E. W.]
A role for the SWI/SNF complex in tumorigenesis based on its requirement for retinoblastoma induced growth arrest and p53-mediated transcription and the appearance of tumors in SWI/SNF-deficient mice. In addition, Western blot data have shown that the SWI/SNF ATPase subunits cell, BRG1 and BRM (BRG1/BRM), are lost in
30% of human non-small lung cancer cell lines. To determine whether loss of expression of these proteins occurs in primary tumors, we examined their expression in 41 primary lung adenocarcinomas and 19 primary lung squamous carcinomas by immunohistochemistry. These analyses showed that 10% of tumors show a concomitant loss of BRG1 and BRM expression. Moreover, patients with BRG1/BRM-negative carcinomas, independent of stage, have a statistically significant decrease in survival compared with patients with BRG1/BRM. This report provides supportive evidence that BRG1 and BRM act as tumor suppressor proteins and implicates a role for their loss in the development of non-small cell lung cancers.
This article has been cited by other articles:
![]() |
T. Fujita, J. Igarashi, E. R. Okawa, T. Gotoh, J. Manne, V. Kolla, J. Kim, H. Zhao, B. R. Pawel, W. B. London, et al. CHD5, a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas J Natl Cancer Inst, July 2, 2008; 100(13): 940 - 949. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Link, S. Balasubramaniam, A. Sharma, C. E.S. Comstock, S. Godoy-Tundidor, N. Powers, K. H. Cao, A. Haelens, F. Claessens, M. P. Revelo, et al. Targeting the BAF57 SWI/SNF Subunit in Prostate Cancer: A Novel Platform to Control Androgen Receptor Activity Cancer Res., June 15, 2008; 68(12): 4551 - 4558. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Glaros, G. M. Cirrincione, A. Palanca, D. Metzger, and D. Reisman Targeted Knockout of BRG1 Potentiates Lung Cancer Development Cancer Res., May 15, 2008; 68(10): 3689 - 3696. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xi, W. He, X. H.-F. Zhang, H.-V. Le, and J. Massague Genome-wide Impact of the BRG1 SWI/SNF Chromatin Remodeler on the Transforming Growth Factor Transcriptional Program J. Biol. Chem., January 11, 2008; 283(2): 1146 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, J. Zhang, and X. Chen The Activity of p53 Is Differentially Regulated by Brm- and Brg1-containing SWI/SNF Chromatin Remodeling Complexes J. Biol. Chem., December 28, 2007; 282(52): 37429 - 37435. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yamamichi, K.-i. Inada, M. Ichinose, M. Yamamichi-Nishina, T. Mizutani, H. Watanabe, K. Shiogama, M. Fujishiro, T. Okazaki, N. Yahagi, et al. Frequent Loss of Brm Expression in Gastric Cancer Correlates with Histologic Features and Differentiation State Cancer Res., November 15, 2007; 67(22): 10727 - 10735. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Gunawardena, S. R. Fox, H. Siddiqui, and E. S. Knudsen SWI/SNF Activity Is Required for the Repression of Deoxyribonucleotide Triphosphate Metabolic Enzymes via the Recruitment of mSin3B J. Biol. Chem., July 13, 2007; 282(28): 20116 - 20123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, T. Ohta, A. Maruyama, T. Hosoya, K. Nishikawa, J. M. Maher, S. Shibahara, K. Itoh, and M. Yamamoto BRG1 Interacts with Nrf2 To Selectively Mediate HO-1 Induction in Response to Oxidative Stress Mol. Cell. Biol., November 1, 2006; 26(21): 7942 - 7952. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bilodeau, S. Vallette-Kasic, Y. Gauthier, D. Figarella-Branger, T. Brue, F. Berthelet, A. Lacroix, D. Batista, C. Stratakis, J. Hanson, et al. Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes & Dev., October 15, 2006; 20(20): 2871 - 2886. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Coisy-Quivy, O. Disson, V. Roure, C. Muchardt, J.-M. Blanchard, and J.-C. Dantonel Role for brm in cell growth control. Cancer Res., May 15, 2006; 66(10): 5069 - 5076. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Nagl Jr., A. Patsialou, D. S. Haines, P. B. Dallas, G. R. Beck Jr., and E. Moran The p270 (ARID1A/SMARCF1) Subunit of Mammalian SWI/SNF-Related Complexes Is Essential for Normal Cell Cycle Arrest Cancer Res., October 15, 2005; 65(20): 9236 - 9244. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, R. A. Baiocchi, S. Pal, G. Mosialos, M. Caligiuri, and S. Sif The BRG1- and hBRM-Associated Factor BAF57 Induces Apoptosis by Stimulating Expression of the Cylindromatosis Tumor Suppressor Gene Mol. Cell. Biol., September 15, 2005; 25(18): 7953 - 7965. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Melnick, K. Adelson, and J. D. Licht The Theoretical Basis of Transcriptional Therapy of Cancer: Can It Be Put Into Practice? J. Clin. Oncol., June 10, 2005; 23(17): 3957 - 3970. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Bhalla Epigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies J. Clin. Oncol., June 10, 2005; 23(17): 3971 - 3993. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gibbons Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R85 - R92. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Medina, J. Carretero, E. Ballestar, B. Angulo, F. Lopez-Rios, M. Esteller, and M. Sanchez-Cespedes Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells Hum. Mol. Genet., April 1, 2005; 14(7): 973 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ma, M. J. Chang, R. Shah, J. Adamski, X. Zhao, and E. N. Benveniste Brg-1 Is Required for Maximal Transcription of the Human Matrix Metalloproteinase-2 Gene J. Biol. Chem., October 29, 2004; 279(44): 46326 - 46334. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Lund and M. van Lohuizen Epigenetics and cancer Genes & Dev., October 1, 2004; 18(19): 2315 - 2335. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Zraly, D. R. Marenda, and A. K. Dingwall SNR1 (INI1/SNF5) Mediates Important Cell Growth Functions of the Drosophila Brahma (SWI/SNF) Chromatin Remodeling Complex Genetics, September 1, 2004; 168(1): 199 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Gunawardena, H. Siddiqui, D. A. Solomon, C. N. Mayhew, J. Held, S. P. Angus, and E. S. Knudsen Hierarchical Requirement of SWI/SNF in Retinoblastoma Tumor Suppressor-mediated Repression of Plk1 J. Biol. Chem., July 9, 2004; 279(28): 29278 - 29285. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fukuoka, T. Fujii, J. H. Shih, T. Dracheva, D. Meerzaman, A. Player, K. Hong, S. Settnek, A. Gupta, K. Buetow, et al. Chromatin Remodeling Factors and BRM/BRG1 Expression as Prognostic Indicators in Non-Small Cell Lung Cancer Clin. Cancer Res., July 1, 2004; 10(13): 4314 - 4324. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Medjkane, E. Novikov, I. Versteege, and O. Delattre The Tumor Suppressor hSNF5/INI1 Modulates Cell Growth and Actin Cytoskeleton Organization Cancer Res., May 15, 2004; 64(10): 3406 - 3413. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Oruetxebarria, F. Venturini, T. Kekarainen, A. Houweling, L. M. P. Zuijderduijn, A. Mohd-Sarip, R. G. J. Vries, R. C. Hoeben, and C. P. Verrijzer p16INK4a Is Required for hSNF5 Chromatin Remodeler-induced Cellular Senescence in Malignant Rhabdoid Tumor Cells J. Biol. Chem., January 30, 2004; 279(5): 3807 - 3816. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Hendricks, F. Shanahan, and E. Lees Role for BRG1 in Cell Cycle Control and Tumor Suppression Mol. Cell. Biol., January 1, 2004; 24(1): 362 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
Genomic Response of Saccharomyces cerevisiae to Radical Mediated DNA Damage: JOSEPH P. COSGROVE, THOMAS J. BEGLEY, AND PETER C. DEDON, Division of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Toxicol Pathol, January 1, 2004; 32(1): 166 - 166. [PDF] |
||||
![]() |
S. Pal, R. Yun, A. Datta, L. Lacomis, H. Erdjument-Bromage, J. Kumar, P. Tempst, and S. Sif mSin3A/Histone Deacetylase 2- and PRMT5-Containing Brg1 Complex Is Involved in Transcriptional Repression of the Myc Target Gene cad Mol. Cell. Biol., November 1, 2003; 23(21): 7475 - 7487. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |